- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Lupin names K B S Anand, Dr Punita Kumar Sinha as independent directors
Mumbai: Pharma major Lupin Limited has announced the appointment of Mr. K.B.S. Anand and Dr. Punita Kumar-Sinha as Independent Directors.
Mr. K.B.S. Anand most recently served as Managing Director and Chief Executive Officer at Asian Paints, India's leading paint company. With a career spanning over four decades at Asian Paints, Mr. Anand worked across manufacturing, sales and marketing functions. He was nominated as the 'Best CEO - Private Sector' at the Forbes Leadership Awards in 2016 and was awarded the Qimpro Gold Standard in Business for Quality in 2017. He currently serves as an Independent Director on the Board of Marico, Tata Chemicals and Borosil.
Mr. Anand holds a B. Tech in Mechanical Engineering from Indian Institute of Technology (IIT), Mumbai, and a PGDM from Indian Institute of Management (IIM), Kolkata.
Dr. Punita Kumar-Sinha brings significant governance and investment experience across India and North America. In her three decade career, she pioneered some of the first foreign investments into the Indian equity markets in the early 1990s. She founded Pacific Paradigm Advisors, an independent investment advisory and management firm, and was formerly a Senior Managing Director at Blackstone. She serves as an Independent Director for several companies including Infosys, JSW Steel, Blackstone Embassy REIT and Rallis.
Dr. Kumar-Sinha is also on the Board of Governors of the CFA Institute (the premier global association for investment management professionals) and has been awarded the Distinguished Alumni Award from Indian Institute of Technology (IIT), New Delhi. Dr. Kumar-Sinha holds a PhD and a Master's in Finance from the Wharton School, University of Pennsylvania. She received her B. Tech in Chemical Engineering with Distinction from Indian Institute of Technology (IIT), New Delhi. She is a CFA charter holder, a TiE Charter Member, and a member of the Council on Foreign Relations.
Commenting on the appointment, Manju D. Gupta, Chairman, Lupin said, "We are delighted to welcome Mr. K.B.S. Anand and Dr. Punita Kumar-Sinha to our board. With their long and illustrious careers, they bring decades of experience in key areas such as innovation, strategy, capital markets and financial expertise that are crucial to Lupin's future operations and strategy".
Read also: Anand K Appointed As New CEO Of SRL Limited
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751